KMT2A and leukemia: MLL translocations are present in about 6% of pediatric leukaemia patients, especially in infants with ALL where about 75% of patients are MLL-rearranged, and their presence predicts early relapse and poor prognosis (event-free survival of 28–45%) [16], [17].